Researchers have successfully treated two patients with the autoimmune disease systemic lupus erythematosus. Using daratumumab, a monoclonal antibody which targets specific immune cells known as plasma cells, the researchers were able to modulate the abnormal immunological memory processes found in these patients. Treatment induced sustainable clinical responses and resulted in a reduction in systemic inflammation.
from Latest Science News -- ScienceDaily https://ift.tt/2HoG75d
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment